Logo

Estonian Genome Project s Funding Uncertain

Apr 29, 2004

NEW YORK, April 28 (GenomeWeb News) - The Estonian Genome Project has lost its funding beyond the end of the year, according to news reports.

 

California-based EGeen, the project's sponsor, provided €1.6 million in early April, but is not planning to grant further funding unless a dispute over the project's direction is resolved, according to The Scientist. The current funding would only keep the project going until November.

 

The Estonian government granted the project €225,000 in January when the dispute erupted.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.